Telegram Group & Telegram Channel
گروه پژوهشی ریسرچ پرو برگزار میکند؛

ریسرچ پوزیشن یا PhD؟
تفاوت ها و فرصت ها-پژوهش در ارتوپدی

میهمان:
دکتر امیرهومن هویدایی

Research Fellow, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, MD, USA (2023 - Present)
 
Senior Research Fellow (Ortho & Tr.), Sports Medicine Research Center, TUMS, IR (2021 - 2023)
 
National Outstanding Researcher, MOHME, IR (2020)
 
Medical Equipment Inventor - National and International
 
Secretary, Representatives’ council of Medical School, SUMS, IR (2016 - 2019)

زمان برگزاری:
پنجشنبه،۲۰ مهر،ساعت ۲۰:۰۰ به وقت تهران


ثبت نام:
https://eseminar.tv/wb121562

✉️ارتباط و پشتیبانی:
@researchpro_admin

🆔 کانال تلگرام:
@researchprogroup



tg-me.com/researchprogroup/170
Create:
Last Update:

گروه پژوهشی ریسرچ پرو برگزار میکند؛

ریسرچ پوزیشن یا PhD؟
تفاوت ها و فرصت ها-پژوهش در ارتوپدی

میهمان:
دکتر امیرهومن هویدایی

Research Fellow, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, MD, USA (2023 - Present)
 
Senior Research Fellow (Ortho & Tr.), Sports Medicine Research Center, TUMS, IR (2021 - 2023)
 
National Outstanding Researcher, MOHME, IR (2020)
 
Medical Equipment Inventor - National and International
 
Secretary, Representatives’ council of Medical School, SUMS, IR (2016 - 2019)

زمان برگزاری:
پنجشنبه،۲۰ مهر،ساعت ۲۰:۰۰ به وقت تهران


ثبت نام:
https://eseminar.tv/wb121562

✉️ارتباط و پشتیبانی:
@researchpro_admin

🆔 کانال تلگرام:
@researchprogroup

BY Research Pro




Share with your friend now:
tg-me.com/researchprogroup/170

View MORE
Open in Telegram


Research Pro Telegram | DID YOU KNOW?

Date: |

However, analysts are positive on the stock now. “We have seen a huge downside movement in the stock due to the central electricity regulatory commission’s (CERC) order that seems to be negative from 2014-15 onwards but we cannot take a linear negative view on the stock and further downside movement on the stock is unlikely. Currently stock is underpriced. Investors can bet on it for a longer horizon," said Vivek Gupta, director research at CapitalVia Global Research.

At a time when the Indian stock market is peaking and has rallied immensely compared to global markets, there are companies that have not performed in the last 10 years. These are definitely a minor portion of the market considering there are hundreds of stocks that have turned multibagger since 2020. What went wrong with these stocks? Reasons vary from corporate governance, sectoral weakness, company specific and so on. But the more important question is, are these stocks worth buying?

Research Pro from us


Telegram Research Pro
FROM USA